Bio Path Holdings, Inc. financial data

Symbol
BPTH on OTC
Industry
Pharmaceutical Preparations
Location
4710 Bellaire Boulevard, Suite 210, Bellaire, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
OGDEN GOLF CO CORP (to 2/19/2008)
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 98.8 % -73.8%
Debt-to-equity -826 % -1715%
Return On Equity 2.09K %
Return On Assets -288 % -15.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.31M shares +1124%
Common Stock, Shares, Outstanding 5.77M shares +833%
Entity Public Float 5.04M USD -62.7%
Common Stock, Value, Issued 6K USD +500%
Weighted Average Number of Shares Outstanding, Basic 2.4M shares +402%
Weighted Average Number of Shares Outstanding, Diluted 2.4M shares +402%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.3M USD -37.2%
General and Administrative Expense 4.7M USD +10.9%
Operating Income (Loss) -12M USD +24.3%
Nonoperating Income (Expense) 2.1M USD +62.2%
Net Income (Loss) Attributable to Parent -9.89M USD +38.5%
Earnings Per Share, Basic -4.12 USD/shares +87.7%
Earnings Per Share, Diluted -4.12 USD/shares +87.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 1.53M USD +12.6%
Assets, Current 3.78M USD +24.1%
Property, Plant and Equipment, Net 23K USD -69.7%
Operating Lease, Right-of-Use Asset 84K USD -17.6%
Assets 3.88M USD +20.6%
Accounts Payable, Current 1.27M USD +179%
Accrued Liabilities, Current 1.94M USD +44%
Liabilities, Current 3.3M USD +72.9%
Operating Lease, Liability, Noncurrent 3K USD -96.5%
Liabilities 3.73M USD +34.2%
Retained Earnings (Accumulated Deficit) -118M USD -9.2%
Stockholders' Equity Attributable to Parent 154K USD -65.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 154K USD -65.1%
Liabilities and Equity 3.88M USD +20.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.27M USD
Net Cash Provided by (Used in) Financing Activities 7.22M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 5.77M shares +833%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.95M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.17M USD +11.5%
Deferred Tax Assets, Valuation Allowance 27.6M USD +14.3%
Deferred Tax Assets, Gross 27.6M USD +14.3%
Operating Lease, Liability 83K USD -26.5%
Depreciation 28K USD
Lessee, Operating Lease, Liability, to be Paid 86K USD -27.7%
Property, Plant and Equipment, Gross 1.08M USD -3.84%
Operating Lease, Liability, Current 83K USD -19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11K USD -89.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 86K USD -20.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3K USD -50%
Deferred Tax Assets, Operating Loss Carryforwards 19.3M USD +3.84%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 118M USD +8.89%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 17K USD -19%
Share-based Payment Arrangement, Expense 900K USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%